A detailed history of High Tower Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 3,065,122 shares of PFE stock, worth $85.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,065,122
Previous 2,835,832 8.09%
Holding current value
$85.8 Million
Previous $81.6 Million 4.18%
% of portfolio
0.14%
Previous 0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$25.89 - $29.73 $5.94 Million - $6.82 Million
229,290 Added 8.09%
3,065,122 $85.1 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $11.3 Million - $14.6 Million
-430,898 Reduced 13.19%
2,835,832 $81.6 Million
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $615,036 - $718,916
-19,166 Reduced 0.58%
3,266,730 $108 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $745,914 - $863,005
-20,651 Reduced 0.62%
3,285,896 $121 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $12 Million - $15.6 Million
-304,170 Reduced 8.42%
3,306,547 $135 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $10.3 Million - $13.4 Million
246,101 Added 7.31%
3,610,717 $185 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $7.79 Million - $9.51 Million
-178,029 Reduced 5.03%
3,364,616 $147 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $310,773 - $368,480
-6,679 Reduced 0.19%
3,542,645 $186 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $20.2 Million - $25.1 Million
-442,238 Reduced 11.08%
3,549,324 $184 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $13.7 Million - $20.3 Million
330,771 Added 9.04%
3,991,562 $236 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $12.5 Million - $16.1 Million
319,130 Added 9.55%
3,660,791 $157 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $6.94 Million - $7.86 Million
193,291 Added 6.14%
3,341,661 $131 Million
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $5.05 Million - $5.69 Million
150,715 Added 5.03%
3,148,370 $114 Million
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $14.2 Million - $18.1 Million
425,521 Added 16.54%
2,997,655 $110 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $13.3 Million - $15.6 Million
417,856 Added 19.4%
2,572,134 $94.4 Million
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $4.61 Million - $5.6 Million
153,170 Added 7.65%
2,154,278 $70.4 Million
Q1 2020

May 21, 2020

BUY
$27.03 - $38.62 $5.89 Million - $8.41 Million
217,853 Added 12.22%
2,001,108 $65.3 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $471,677 - $535,294
-14,328 Reduced 0.8%
1,783,255 $70 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $3.43 Million - $4.45 Million
105,642 Added 6.24%
1,797,583 $64.6 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $6.22 Million - $6.99 Million
-168,286 Reduced 9.05%
1,691,941 $73.2 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $982,687 - $1.08 Million
26,205 Added 1.43%
1,860,227 $78.9 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $2.76 Million - $3.15 Million
71,747 Added 4.07%
1,834,022 $80 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $1.66 Million - $2.01 Million
-48,094 Reduced 2.66%
1,762,275 $77.6 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $875,882 - $933,779
-26,558 Reduced 1.45%
1,810,369 $65.7 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $445,974 - $517,391
-13,976 Reduced 0.76%
1,836,927 $65.2 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $1.05 Million - $1.11 Million
31,576 Added 1.74%
1,850,903 $67 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $14 Million - $15.4 Million
-452,359 Reduced 19.91%
1,819,327 $65 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,271,686
2,271,686 $76.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.